MARZO, TIZIANO
 Distribuzione geografica
Continente #
NA - Nord America 5.484
EU - Europa 2.916
AS - Asia 1.652
SA - Sud America 278
Continente sconosciuto - Info sul continente non disponibili 122
AF - Africa 45
OC - Oceania 19
Totale 10.516
Nazione #
US - Stati Uniti d'America 5.415
RU - Federazione Russa 901
IT - Italia 661
PL - Polonia 522
SG - Singapore 448
CN - Cina 365
HK - Hong Kong 262
IE - Irlanda 231
BR - Brasile 223
VN - Vietnam 218
SE - Svezia 127
KR - Corea 117
FI - Finlandia 101
NL - Olanda 77
DE - Germania 74
GB - Regno Unito 68
FR - Francia 66
IN - India 59
JO - Giordania 43
CA - Canada 41
ID - Indonesia 31
AR - Argentina 23
JP - Giappone 21
UA - Ucraina 20
AU - Australia 19
BD - Bangladesh 19
ES - Italia 18
TR - Turchia 16
MX - Messico 15
BE - Belgio 13
CH - Svizzera 13
ZA - Sudafrica 11
IQ - Iraq 10
CI - Costa d'Avorio 9
CO - Colombia 8
NG - Nigeria 8
EC - Ecuador 7
UZ - Uzbekistan 6
AT - Austria 5
BG - Bulgaria 5
MA - Marocco 5
PK - Pakistan 5
AZ - Azerbaigian 4
CL - Cile 4
PE - Perù 4
PH - Filippine 4
SA - Arabia Saudita 4
TN - Tunisia 4
VE - Venezuela 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
IL - Israele 3
PY - Paraguay 3
RO - Romania 3
AL - Albania 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 10.399
Città #
Santa Clara 991
Ashburn 602
Warsaw 521
Fairfield 505
Singapore 314
Chandler 251
Woodbridge 245
Dublin 231
Seattle 213
Hong Kong 212
Houston 194
Cambridge 182
Wilmington 156
San Jose 137
Ann Arbor 120
Seoul 116
Beijing 112
Florence 109
Milan 108
Lawrence 89
Altamura 87
Amsterdam 70
New York 70
Princeton 68
Ho Chi Minh City 66
Los Angeles 60
Council Bluffs 59
Buffalo 53
Hanoi 52
Moscow 52
Boston 47
The Dalles 45
Rome 44
Lauterbourg 43
Helsinki 42
Munich 40
Clifton 39
Mumbai 32
Turku 32
Dallas 27
Shanghai 25
Medford 24
Chicago 19
Jakarta 19
Melbourne 18
San Diego 18
Boardman 16
Hefei 16
London 16
Tokyo 16
Naples 14
Toronto 14
Brussels 13
São Paulo 13
Orem 12
Barcelona 11
Redondo Beach 11
Bern 10
Haiphong 10
Kent 10
Miano 10
Paris 10
Abidjan 9
Brooklyn 9
Dong Ket 9
Jacksonville 9
Rio de Janeiro 9
Abuja 8
Da Nang 8
Figino 8
Serra 8
Atlanta 7
Cagliari 7
Falls Church 7
Genoa 7
Manchester 7
Norwalk 7
Phoenix 7
Tianjin 7
Yubileyny 7
Baghdad 6
Charlotte 6
Frankfurt am Main 6
Montreal 6
Porto Alegre 6
San Francisco 6
Stockholm 6
Tashkent 6
Turin 6
Biên Hòa 5
Bologna 5
Chennai 5
Denver 5
Hillsboro 5
Johannesburg 5
Lappeenranta 5
Lấp Vò 5
New Delhi 5
Padua 5
Pisa 5
Totale 7.010
Nome #
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 667
FROM CONVENTIONAL TO NOVEL Pt-BASED ANTINEOPLASTIC AGENTS: MECHANISTIC ASPECTS AND BIOLOGICAL EFFECTS 375
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 341
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 337
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 335
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin 321
Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes 318
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study 274
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 254
PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features 248
Auranofin and its Analogues Show Potent Antimicrobial Activity Covering Multiresistant Pathogens: Structure-Activity Relationships 233
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells 220
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 202
Diruthenium Diacetate-Catalyzed Aerobic Oxidation of Hydroxylamines and Improved Chemoselectivity by Immobilization to Lysozyme 199
Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies 196
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems 196
Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles 196
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 193
A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex 192
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent 186
Synthesis, characterization and DNA interactions of [Pt3(TPymT)Cl3], the trinuclear platinum(II) complex of the TPymT ligand 185
cis-Pt I2(NH3)2: a reappraisal 184
ESI-MS studies of the reactions of novel platinum(II) complexes containing O,O'-chelated acetylacetonate and sulfur ligands with selected model proteins 181
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation 177
Cytotoxic activity and protein binding through an unusual oxidative mechanism by an iridium(I)–NHC complex 176
Protein Metalation by Anticancer Metallodrugs: A Joint ESI MS and XRD Investigative Strategy 175
Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems 175
Reaction with proteins of a five-coordinate platinum(II) compound 174
Oxaliplatin vs. cisplatin: Competition experiments on their binding to lysozyme 170
Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections 164
Reactions of Cytotoxic Metallodrugs with Lysozyme in pure DMSO explored through UV-Vis Absorption Spectroscopy and ESI MS 153
Interaction of a gold(i) dicarbene anticancer drug with human telomeric DNA G-quadruplex: solution and computationally aided X-ray diffraction analysis 153
The cisplatin/serum albumin system: A reappraisal 152
Interplay of crystallography, Raman microspectroscopy and electrospray mass spectrometry for studying the reaction between ruthenium complexes and proteins 145
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 143
Synthesis and Mode of Action Studies on Iridium(I)–NHC Anticancer Drug Candidates 138
Interactions between Anticancertrans-Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts oftrans-(Dimethylamino)(methylamino)dichloridoplatinum(II) 135
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding 133
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules 130
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study 130
Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activity 129
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 129
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 128
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study 128
The X-ray structure of the complex formed in the reaction between oxaliplatin and lysozyme 127
Mechanistic studies on cytotoxic gold compounds 125
Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins 125
Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution 124
Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis 124
Peculiar Features in the Crystal Structure of the Adduct Formed betweencis-PtI2(NH3)2and Hen Egg White Lysozyme 122
A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin 117
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 115
Interactions of carboplatin and oxaliplatin with proteins: Insights from X-ray structures and mass spectrometry studies of their ribonuclease A adducts 113
Unusual Structural Features in the Lysozyme Derivative of the Tetrakis(acetato)chloridodiruthenium(II,III) Complex 107
null 47
null 31
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 26
The impact of albumin conjugation on the cytotoxic properties of cisplatin, oxaliplatin and auranofin in cancer cells 25
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study (2022) Inorganic Chemistry 16
null 2
Totale 10.516
Categoria #
all - tutte 27.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022398 0 25 32 13 28 16 11 48 28 25 52 120
2022/20231.056 101 254 44 77 61 175 144 50 93 7 24 26
2023/2024412 16 32 64 10 21 91 24 95 9 19 13 18
2024/20252.533 86 275 155 380 804 428 34 77 57 56 104 77
2025/20263.341 279 362 175 290 306 116 344 126 264 201 522 356
2026/2027108 101 7 0 0 0 0 0 0 0 0 0 0
Totale 10.516